Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Cash Flow-to-Debt Ratio
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Cash Flow-to-Debt Ratio of -0.16x as of March 2026, meaning its operating cash flow of ₫-135.66 Billion could theoretically repay 0% of its total liabilities (₫870.62 Billion) in one year. See Binh Dinh Pharmaceutical and Medical Equ free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Binh Dinh Pharmaceutical and Medical Equipment JSC across 6 annual periods. Also explore net asset growth rate of Binh Dinh Pharmaceutical and Medical Equ to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Year-by-year debt coverage analysis for Binh Dinh Pharmaceutical and Medical Equipment JSC. For market capitalisation and broader financial context, see Binh Dinh Pharmaceutical and Medical Equ market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (VND) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | ₫615.19 Billion | ₫862.89 Billion | ▲ +62.4% |
| 2024 | 0.44x | ₫264.73 Billion | ₫603.07 Billion | ▼ -17.0% |
| 2023 | 0.53x | ₫293.99 Billion | ₫556.07 Billion | ▲ +73.2% |
| 2022 | 0.31x | ₫165.01 Billion | ₫540.58 Billion | ▲ +8.8% |
| 2021 | 0.28x | ₫117.57 Billion | ₫418.97 Billion | ▼ -40.9% |
| 2020 | 0.47x | ₫212.91 Billion | ₫448.78 Billion | — |